We condemn the targeted narrative against COVAXIN put forth by a select few individuals and groups who have no expertise in vaccines or vaccinology. It is well known that they helped perpetuate misinformation and fake news throughout the pandemic.
More than 89,000 individuals suffered adverse reactions, of whom 1,148 died. The government’s inefficient response left families without information or support.
"Ocugen, Inc (NASDAQ: OCGN) announced that the US Food and Drug Administration (FDA) has lifted its clinical hold on the Company s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate, BBV152, known as Covaxin outside the United States. Covaxin to Be Evaluated as COVID-19 Vaccine Candidate in US, Says Bharat Biotech.
Vaccination opens for teens in the 15 to 18 age group from today amid a surge of Covid cases in multiple cities. Over 8 lakh teens have registered in the government's CoWin portal and all will get a dose of Covaxin.